全文获取类型
收费全文 | 8344篇 |
免费 | 725篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 85篇 |
儿科学 | 274篇 |
妇产科学 | 161篇 |
基础医学 | 1093篇 |
口腔科学 | 166篇 |
临床医学 | 906篇 |
内科学 | 1568篇 |
皮肤病学 | 156篇 |
神经病学 | 630篇 |
特种医学 | 246篇 |
外科学 | 1241篇 |
综合类 | 91篇 |
一般理论 | 11篇 |
预防医学 | 1017篇 |
眼科学 | 133篇 |
药学 | 595篇 |
中国医学 | 4篇 |
肿瘤学 | 708篇 |
出版年
2023年 | 111篇 |
2022年 | 204篇 |
2021年 | 442篇 |
2020年 | 248篇 |
2019年 | 367篇 |
2018年 | 424篇 |
2017年 | 293篇 |
2016年 | 295篇 |
2015年 | 309篇 |
2014年 | 432篇 |
2013年 | 496篇 |
2012年 | 752篇 |
2011年 | 703篇 |
2010年 | 379篇 |
2009年 | 258篇 |
2008年 | 468篇 |
2007年 | 359篇 |
2006年 | 351篇 |
2005年 | 313篇 |
2004年 | 324篇 |
2003年 | 232篇 |
2002年 | 255篇 |
2001年 | 90篇 |
2000年 | 71篇 |
1999年 | 78篇 |
1998年 | 40篇 |
1997年 | 45篇 |
1996年 | 43篇 |
1995年 | 31篇 |
1994年 | 35篇 |
1992年 | 34篇 |
1991年 | 35篇 |
1990年 | 52篇 |
1989年 | 49篇 |
1988年 | 37篇 |
1987年 | 24篇 |
1986年 | 20篇 |
1985年 | 31篇 |
1984年 | 19篇 |
1983年 | 17篇 |
1979年 | 19篇 |
1978年 | 28篇 |
1977年 | 18篇 |
1976年 | 23篇 |
1975年 | 16篇 |
1974年 | 17篇 |
1973年 | 23篇 |
1972年 | 20篇 |
1969年 | 21篇 |
1967年 | 14篇 |
排序方式: 共有9085条查询结果,搜索用时 15 毫秒
101.
102.
Background
Advanced Practice Registered Nurses (APRNs) provide access to cost-effective, high quality care. APRNs are underutilized in states that restrict their practice. Removing restrictions could expand access to quality health care, cost-effectively relieve the physician shortage, and contribute economically.Purpose
This study forecasts the health system and economic impacts of reducing practice restrictions for Florida APRNs.Methods
The analysis utilized a number of data sources and IMPLAN software and estimated changes in APRN supply given less restrictive practice laws, and consequential health system and economic benefits.Findings
Between 2013 and 2025 APRN full time equivalents could increase an additional 11% with less restrictive practice regulations. This could eliminate or reduce the shortage of different types of physicians. Health care cost-savings could be $50 to $493 per resident. There would be a number of general economic benefits.Discussion
A number of health system and economic benefits would ensue from less restrictive APRN regulation. 相似文献103.
Ofir Moreno Todd Butler Vanessa Zann Ashley Willson Pui Leung Alyson Connor 《Clinical therapeutics》2018,40(11):1855-1867
Purpose
ME-401 is a novel selective inhibitor of phosphatidylinositol 3 kinase p110δ, an enzyme often found overexpressed and overactive in B-cell malignancies. The current study was performed to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending oral doses of ME-401 in healthy volunteers.Methods
This analysis was an open-label, nonrandomized study in healthy male volunteers. Three sequential groups were dosed. Each group received single doses of ME-401 on two occasions; the doses tested ranged from 10 to 150 mg. Blood was drawn at various time points to analyze plasma concentrations of ME-401 and inhibition of basophil activation, a marker of phosphatidylinositol 3 kinase p110δ inhibition.Findings
Fifteen subjects received a single dose of ME-401 on two occasions. Three adverse events that were considered possibly related to the study drug were reported: one event of pain, one event of headache, and one event of upper abdominal pain. ME-401 exhibited dose proportionality up to 60 mg, and supra-proportional increases in exposure were observed above doses of 60 mg. In addition, there was a dose-proportional increase in the inhibition of basophil activation up to 60 mg. Mean t1/2 ranged from 9.36 to 29.23 hours across the dose range. A 60 mg dose of ME-401 approached 90% inhibition of basophil activation, and thereafter no further increase to the percent inhibition of basophil activation was observed for higher doses. Once-daily dosing of 60 mg ME-401 was forecasted to result in trough plasma levels exceeding the concentration needed for 90% inhibition of basophil activation.Implications
This first-in-human study showed that ME-401 was well tolerated after single doses up to 150 mg. Pharmacologic activity was confirmed after administration of single ascending oral doses of 10 to 150 mg. ME-401 60 mg, administered once daily, was selected as the starting dose for patient studies. ClinicalTrials.gov identifier: NCT02521389. 相似文献104.
Background
Visceral angioedema is a rarely reported side effect of angiotensin-converting-enzyme inhibitors (ACEI). Because signs and symptoms tend to be nonspecific, the diagnosis is difficult to make, especially in the emergency department (ED).Case Report
We describe 2 patients presenting with signs of hypovolemic shock, in which the diagnosis of ACEI-induced visceral angioedema was made in the ED. We surmise that patients with abdominal pain, who present with hypovolemic shock and are taking medications that can predispose to angioedema, may have this complication if their hemoglobin level is elevated compared with their previous levels. An abdominal computed tomography scan, if it does not identify any other significant etiology, will increase the probability that ACEI-induced visceral angioedema is the diagnosis when there is nonspecific bowel wall thickening or edema.Why Should an Emergency Physician Be Aware of This?
Identification of ACEI-induced visceral angioedema in the ED will avoid prolonged admissions, unnecessary procedures, and future recurrences. 相似文献105.
106.
107.
108.
109.
BACKGROUND: Tender points (TPs) and fibromyalgia (FM) may be precipitated by infections, but the frequency, associated characteristics, and predictors of these outcomes are unknown. OBJECTIVES: To determine if acute infectious mononucleosis (AIM) is associated with the development of TPs or FM acutely or during the subsequent 6 months; if demographic, clinical, or psychosocial features predict TPs or FM; and if TPs or FM correlate with nonrecovery. METHODS: A total of 150 subjects diagnosed as having AIM were assessed with physical examinations (including palpation of 18 TPs), laboratory tests, and measures of psychosocial and somatic functioning at enrollment and at 2 and 6 months. Subjects also completed a structured psychiatric interview at the initial evaluation. RESULTS: At presentation and at 2 and 6 months, the mean TP counts were 7.5, 4.6, and 3.0, respectively; at these time points, 19%, 3%, and 1% of subjects also met modified criteria for FM. Tender points and degree of pain diminished over time following AIM. Acutely, TPs were associated only with higher temperature (P<.001). Baseline features that predicted more TPs at 2 and 6 months were female sex, older age, less family social support, and more TPs at presentation. Neither initial laboratory tests nor psychiatric disease or distress predicted TPs. Differences between those who had and had not recovered at 6 months were found for the mean number of TPs (P<.008), the proportion of subjects with 11 or more TPs (P<.002), and the degree of pain. CONCLUSIONS: Tender points are a common, transient finding associated with AIM, but FM is an unusual long-term outcome. Demographic, social, and physical examination features predicted TPs. 相似文献
110.
The galvanization of beta-amyloid in Alzheimer's disease 总被引:5,自引:0,他引:5